Brief: Bellerophon Says Q4 Loss Per Share $0.84
11/03/2021 14:06
March 11 (Reuters) - Bellerophon Therapeutics Inc BLPH.O :
* BELLEROPHON PROVIDES CLINICAL PROGRAM UPDATE AND REPORTS
FOURTH
QUARTER AND FULL-YEAR 2020 FINANCIAL RESULTS
* Q4 LOSS PER SHARE $0.84
* Q4 EARNINGS PER SHARE ESTIMATE $-0.90 -- REFINITIV IBES
DATA
Source text for Eikon: ID:nGNX34rBKY
Further company coverage: BLPH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bellerophon Therapeutics
See all newsBrief: Bellerophon Therapeutics Inc On October 12, 2023, Board Of Directors Approved Plan Of Liquidation And Dissolution Of Company
Bellerophon Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Bellerophon Therapeutics Inc expected to post a loss of 42 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Archer-Daniels-Midland, Nucor, Copper miners
U.S. STOCKS ON THE MOVE-Hubbell, Spire Global, FibroGen